Daniel Wang

9.9k citations
58 papers · 2.2k · 2 hit papers · h-index 21

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • T-cell and B-cell Immunology
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 21
    • CAR-T cell therapy research 10
    • Colorectal Cancer Treatments and Studies 5
    • Immunotherapy and Immune Responses 11
    • Immune Cell Function and Interaction 6
    • Immune cells in cancer 4

Daniel Wang

53 papers receiving 2.2k citations

Daniel Wang's Hit Papers

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme 2014 · 409 citations
4090+7+14Years since publication200400600

Peers

Daniel Wang
Comparison fields: 5 of 123
  • Immunology 811
  • Oncology 800
  • Physiology 84
  • Epidemiology 461
  • Software 39
Replace Fan Xia with:
Fan Xia China
Hai‐Ning Chen China
Wenbin Qian China
Yong Cai China
Tadakazu Kondo Japan
Janice M. Mehnert United States
Sabina Berezowska Switzerland
Yang Meng China
Sasha A. Singh United States
Daniel Wang relative to Fan Xia China Fan Xia's profile →
Citations per field
00.5×7.9×
Fan Xia · 1×
Citations per year

Countries citing papers authored by Daniel Wang

Since Specialization
Citations

This map shows the geographic impact of Daniel Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wang more than expected).

Fields of papers citing papers by Daniel Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wang. The network helps show where Daniel Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Wang Line = papers co-authored together Daniel Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Hit paper breakdown →
2005603
2
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Hit paper breakdown →
2014409
3 2017160
4 2017113
5 201882
6 200677
7 201953
8 201751
9 202051
10 201840
11 201936
12 201735
13 201832
14 200631
15 202030
16 201428
17 202225
18 202124
19 201923
20 200222

About Daniel Wang

Daniel Wang is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 58 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Immune cells in cancer (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Immunology (811 citations), Oncology (800 citations), Physiology (84 citations), Epidemiology (461 citations) and Software (39 citations). Daniel Wang has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Douglas B. Johnson, Zhong Guo, Kui Shin Voo, Yanchun Li, Weiyi Peng, Tihui Fu, Yukiko Kiniwa, Rongfu Wang, Guangyong Peng and Helen Y. Wang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, The Journal of Immunology, Blood, OncoImmunology and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact